Short answer
Medtronic (MDT) filed an 8-K current report with the SEC on September 1, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Medtronic announced first-quarter fiscal 2027 financial results on September 1, 2026.
Medtronic 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Medtronic announced first-quarter fiscal 2027 financial results on September 1, 2026
- Detailed results, guidance, and management commentary are in Exhibit 99.1
- Earnings release provides the basis for assessing fiscal 2027 performance and outlook
Item EX-99.1 · Exhibit EX-99.1
- Q1 FY27 revenue $9.756B, up 13.7% organic, benefiting approximately $570M from the extra fiscal week
- Non-GAAP diluted EPS $1.45, up 15.1%; operating margin 23.7% versus 23.6% prior year
- FY27 organic growth guidance raised to 7.25%-7.75%; non-GAAP EPS guidance increased to $5.94-$6.00
- Cardiovascular led growth at 18.9% organic, including Electrophysiology Therapies at 29.1%
- Portfolio expansion through Scientia Vascular and SPR acquisitions, Pi-Cardia investment, and Cornerstone Robotics partnership
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Medtronic 8-K filings
Get the next MDT 8-K as it lands
Follow MDT for push alerts, or ask the research agent what this filing means.